ELAN-Pilot Projects

P133-OA: Combined targeting of chemoresistant cancer cells and immune-suppressive CAFs for cancer therapy Jan. 1, 2024 - Sept. 30, 2024 P114: Establishment of a data set for the systematic assessment of drug-related hospitalisations in paediatrics April 1, 2023 - Sept. 30, 2024 P126: Mesenteries as a novel ex vivo co-culture model to study peritoneal metastasis May 1, 2023 - Sept. 1, 2024 P152-OA: STAT2-mediated control of type I IFN signaling in colorectal tumorigenesis May 1, 2024 - Aug. 31, 2024 P127-OA: Myocarditis in relation to physical exercise, a prospective analysis of myocarditis and PIMS-TS in children Sept. 1, 2023 - Aug. 31, 2024 P128-OA: FICD-mediated AMPylation: a potential modulator of Parkinson’s disease? Sept. 1, 2023 - Aug. 31, 2024 P119: Analysis of intestinal tryptophan metabolites as factors in inflammation and extraintestinal manifestations Aug. 1, 2023 - July 31, 2024 P134: Untargeted metabolomics in adrenal tumors: Screening for novel diagnostic biomarkers in urine Aug. 1, 2023 - July 31, 2024 P129: Development of biofabricated 3D breast cancer in a perfusion reactor as tumor angiogenesis and therapy model Aug. 1, 2023 - July 31, 2024 P118: GPR179 and LRRTM4: two new players in night vision accociated with GABA receptors Feb. 1, 2023 - July 31, 2024